Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2026-05-12 16:09:15 ET · period of report 2025-12-16 · accession 0001792164-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-12 16:09 | 2025-12-16 | RCUS | Ribas Antoni | Dir | G - Gift | $0.00 | -5,050 | 38.6K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-16 | G | D | 5,050 | $0.00 | 38,600 | D | — | — | (F1) Gift to family members for estate planning purposes. (F2) Includes the unvested portion of the reporting person's RSU grants. |